Pyxis Oncology Inc (PYXS) Insider Trading
- $5,526,566.54
- $5,394,717.15
- Nov. 26, 2024
- Pamela Ann Connealy
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 26, 2024 | CFO | 88,850 | $1.96 | Buy | $174,146.00 | |
| Sept. 27, 2023 | CFO | 6,426 | $1.85 | Buy | $11,888.10 | |
| Sept. 27, 2023 | CAO | 2,500 | $1.87 | Buy | $4,675.00 | |
| Sept. 25, 2023 | CFO | 12,000 | $1.67 | Buy | $20,040.00 | |
| Sept. 25, 2023 | CAO | 5,000 | $1.77 | Buy | $8,850.00 | |
| Sept. 22, 2023 | CFO | 5,000 | $1.74 | Buy | $8,700.00 | |
| Sept. 22, 2023 | CAO | 2,500 | $1.74 | Buy | $4,350.00 | |
| Sept. 18, 2023 | CEO | 8,541 | $2.10 | Sell | $17,936.10 | |
| Sept. 13, 2023 | CEO | 3,000 | $2.27 | Sell | $6,810.00 | |
| Sept. 11, 2023 | CEO | 20,000 | $2.27 | Sell | $45,400.00 | |
| March 17, 2023 | Major Shareholder | 1,811,594 | $2.76 | Buy | $4,999,999.44 | |
| April 21, 2022 | Director | 1,745,761 | $3.05 | Sell | $5,324,571.05 | |
| Dec. 8, 2021 | Director | 10,000 | $9.39 | Buy | $93,900.00 | |
| Nov. 18, 2021 | Director | 15,700 | $12.74 | Buy | $200,018.00 |
Insiders are both buying and selling Pyxis Oncology Inc stock.
The insider traders at Pyxis Oncology Inc are: Pamela Ann Connealy, Lara Sullivan, Jitendra Wadhane, Thomas Civik, Mark Chin, Darren S Cline, and Pfizer Inc
The most active insider trader at Pyxis Oncology Inc is Pamela Ann Connealy with 4 trades.
Mark Chin has sold the most Pyxis Oncology Inc stock with a total value of $10,649,142.10.
Pfizer Inc has bought the most Pyxis Oncology Inc stock with a total value of $9,999,998.88.
The most recent insider trade for Pyxis Oncology Inc was on Nov. 26, 2024.
The single biggest insider buy for Pyxis Oncology Inc was from Pfizer Inc with a total value of $4,999,999.44 on March 17, 2023.
The single biggest insider sell for Pyxis Oncology Inc was from Mark Chin with a total value of $5,324,571.05 on April 21, 2022.